ArticleMolecular cancer therapeutics2013

Synthetic lethal targeting of PTEN-deficient cancer cells using selective disruption of polynucleotide kinase/phosphatase.

Todd R Mereniuk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.